Abstract
The hemodynamic profile of tolerance to intravenous nitroglycerin was studied in 9 patients with New York Heart Association Class III to IV congestive heart failure. After rapid dosage build-up to the maximal tolerated dose (decrease in pulmonary wedge pressure to 10 mm Hg or systolic blood pressure to 90 mm Hg), nitroglycerin (525 +/- 548 micrograms/min) was administered at a constant continuous intravenous infusion for a total of 24 hours. The extent of nitrate tolerance at 24 hours was calculated as the percentage loss of the benefit achieved at time of peak effect of nitroglycerin. Tolerance had a different time course and magnitude in the venous, arterial and pulmonary circulations. At 24 hours, right atrial pressure and pulmonary vascular resistance returned to control values in most patients, while 40 to 50% of the effect on systemic vascular resistance, cardiac index and pulmonary wedge pressure was maintained. These findings emphasize the importance of precise definitions in studies relating to nitrate tolerance.
References
Mar 1, 1986·Annals of Internal Medicine·R A JordanJ Franciosa
Sep 1, 1986·Circulation·D J StewartE Bassenge
Sep 1, 1987·Circulation·U ElkayamS H Rahimtoola
Sep 24, 1987·The New England Journal of Medicine·M PackerM Yushak
Dec 1, 1986·Circulation·J Abrams
May 1, 1985·Circulation·R A JordanJ A Franciosa
Jul 1, 1985·American Heart Journal·J Abrams
Apr 1, 1983·Circulation·C V LeierD V Unverferth
Jan 1, 1984·Intensive Care Medicine·Y LisD Robson
Apr 1, 1980·The American Journal of Cardiology·F Magrini, A P Niarchos
Nov 1, 1980·European Journal of Clinical Pharmacology·P R ImhofJ Hodler
Dec 1, 1981·The American Journal of Cardiology·C V LeierD V Unverferth
Jan 1, 1983·American Heart Journal·F Magrini, A P Niarchos
Sep 1, 1981·Circulation·M PackerR Gorlin
Citations
Feb 1, 1994·Clinical Cardiology·L H JørgensenE Thaulow
Aug 1, 1995·Clinical Cardiology·L H JørgensenH E Refsum
Sep 1, 1996·Clinical Cardiology·L H JørgensenH E Refsum
Jun 30, 2000·Clinical Cardiology·L H JørgensenH E Refsum
Jan 1, 1997·Cardiovascular Drugs and Therapy·U Thadani
Jan 1, 1993·European Journal of Clinical Pharmacology·M BuschmannH Roskamm
Jun 1, 1994·Cardiovascular Drugs and Therapy·H L Fung, J A Bauer
Feb 1, 1996·American Heart Journal·L PizzulliB Lüderitz
Oct 1, 1992·American Heart Journal·B S LewisL Kahana
Jul 1, 1994·American Heart Journal·N J Mangione, S P Glasser
Sep 1, 1992·Circulation·S GhioG Specchia
Jan 1, 1992·Circulation·S BoesgaardH E Poulsen
Aug 1, 1994·British Heart Journal·S GhioC Montemartini
Apr 1, 1995·Cardiovascular Drugs and Therapy·M J KoolL M Van Bortel